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Background: Reduction of dietary carbohydrates and corresponding insulin doses stabilizes and lowers mean
blood glucose in individuals with type 1 diabetes within days. The long-term adherence for persons who have
learned this technique is unknown. To assess adherence over 4 years in such a group the present audit was done
retrospectively by record analysis for individuals who have attended an educational course. Adherence was
assessed from HbA1c changes and individuals’ own reports.
Findings: Altogether 48 persons with diabetes duration of 24 ± 12 years and HbA1c>= 6.1% (Mono-S;
DCCT = 7.1%) attended the course. Mean HbA1c for all attendees was at start, at 3 months and 4 years 7.6%± 1.0%,
6.3 ± 0.7%, 6.9 ± 1.0% respectively. The number of non-adherent persons was 25 (52%). HbA1c in this group was at
start, at 3 months and 4 years: 7.5 ±1.1%, 6.5 ± 0.8%, 7.4 ± 0.9%. In the group of 23 (48%) adherent persons mean
HbA1c was at start, at 3 months and 4 years 7.7 ± 1.0%, 6.4 ± 0.9%, 6.4 ± 0.8%.
Conclusion: Attending an educational course on dietary carbohydrate reduction and corresponding insulin
reduction in type 1 diabetes gave lasting improvement. About half of the individuals adhered to the program after
4 years. The method may be useful in informed and motivated persons with type 1 diabetes. The number needed
to treat to have lasting effect in 1 was 2.
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Considering the detrimental effect of hyperglycemia
upon all organ systems the achieving of euglycemia or
near-euglycemia is essential in the care of type 1 dia-
betes [1,2]. However, lowering of the mean HbA1c in
DCCT (Diabetes and Control Trial) increased the rate of
severe hypoglycemia threefold [1]. Despite technological
progress such as self monitoring, use of insulin delivery
devices (pens, pumps) the average glycemic control in
type 1 diabetes is poor. In Sweden mean HbA1c in
adults is about 7% (Mono-S method, corresponding to
about 8% DCCT and 63 mmol/mmol, IFCC).
The blood glucose excursions in type 1 diabetes are a
function of the input of glucose from food, mainly carbo-
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reproduction in any medium, provided the orand insulin from subcutaneous insulin stores. The esti-
mation of the amount of carbohydrates in a meal has an
error rate of 50% [3]. The insulin absorption may vary by
up to 30% [4]. It is therefore virtually impossible to
match carbohydrates and insulin which leads to unpre-
dictable blood glucose levels after meals. By reducing the
carbohydrates and insulin doses the size of the blood glu-
cose fluctuations can be minimized. The risk of
hypoglycemia is therefore minimized as well [5,6].
Around-the-clock euglycemia was seen with 40 g carbo-
hydrates in a group of people with type 1 diabetes [7].
The immediate resulting stable, near-normal blood
glucose levels allow individuals to predict after-meal
glucose levels with great accuracy (see Figure 1). This
regimen is little used, but can be an added important
approach for some patients. Also in type 2 diabetes is
reduction of dietary carbohydrates a useful regimen
with lasting effect on all aspect of the metabolic syn-
drome [8].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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Figure 1 An example of blood glucose values in one person
before and after a reduction of carbohydrates and insulin. The
arrow marks the change. There are 25 measurement over 6 days
before the change and 39 measurements over 7 days after. Mean
BG in the left side is 14.0 mmol/l (range: 5.9 to 23.1 mmol/l). Mean
BG in the right side is 6.4 mmol/l (range: 4.0 to 9.5 mmol/l). It is
evident that lowering of the mean blood glucose in the left side of
the figure is impossible without hypoglycemia. Flattening out of the
small spikes in the right side can be done safely.
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evaluation of group education in this regimen has shown
that the short-time lowering of mean HbA1c by 1 per-
centage unit and the reduction in mean rate of symp-
tomatic hypoglycemia by 82% was maintained [9].
All individuals attending the educational course here
have sought it themselves after having had written infor-
mation of the regimen. It is practical guidance based on
the central medicine sciences of physiology, biochemis-
try and pharmacology. It is aimed at normalizing the
blood glucose [5,6]. This approach in almost all indivi-
duals gives the sought effect immediately. But since par-
ticipants in diet studies generally show very poor
adherence to whatever diet they are put on, we have
again done an audit. The purpose is to map adherence
among the individuals with type 1 diabetes, who
attended the educational course at least 4 years earlier.
Methods
Attendees
The attendees were all outpatients. All individuals with
HbA1c>= 6.1% (DDCT: 7.1%) attending the educa-
tional course from the start of 2004 to 2006 and adher-
ing to it for at least the first 4 weeks are reported here.
All patients, dissatisfied with their own glucose control
and looking for ways to improve it, have received
complete information about carbohydrates’ effect on
their blood glucose and the effect of a reduction. It was
then up to themselves to decide whether they wished to
make any changes.
Individuals attended the course in groups of 5-7
people. The course consisted of one whole day fol-
lowed by 4 sessions lasting 2-3 hours once a week over
4 weeks. The regimen is a carbohydrate restricted diet
(carbohydrates 75 g/day or less) in combination withcorrespondingly adapted insulin doses. The method is
described elsewhere [9]. An additional file shows the
methods in more detail [see additional file 1].
Adherence
Adherence was estimated from both HbA1c changes
and an individual’s self reported adherence. The blood
glucose changes the first days show the effect of the
regimen; HbA1c after 3 months shows the effect of
short-time adherence. From then on we have assessed
adherence by comparing individual HbA1c values with
the start and 3-months values. HbA1c continuously at
3 months level or lower suggests good adherence, and
vice versa. Information about adherence to the diet was
obtained from each individual’s own report in the clin-
ical chart.
HbA1c
Some people have a seasonal variation of HbA1c. The
difference in HbA1c over a year appears to be related to
the difference in temperature [10]. For each person we
have therefore primarily used HbA1c taken the same
months each year. If a value was missing the mean of
the two adjacent HbA1cs are used.
HbA1c measurements were done in the same labora-
tory using the Mono-S method used in Sweden. This
method gives values approximately 1 percentage unit
lower than DCCT units. HbA1c (Mono-S) of 6.0% and
8.0% corresponds to HbA1c (DCCT) of approximately
7.0% and 9.0% respectively. This corresponds to
52 mmol/mol and 84 mmol/mol in IFCC units which
is used in some places of Europe (IFCC = International
Federation of Clinical Chemistry and Laboratory
Medicine). Normal values for people below 50 years
are: (Mono-S)< 5.5%, (DCCT) <6.5% and (IFCC)
<46 mmol/mol.
Normal/near normal (<6%) HbA1c values cannot be
expected to change much and are therefore not suitable
to evaluate adherence in this report. Mono-S (%) to
IFCC (mmol/mol) =10.45*[HbA1c]-10.67.
Statistics
Means are given with standard deviation. Two-tailed
t-test for dependent samples is used.
Results
Altogether 48 persons with HbA1c> 6.1% (DCCT: 7.1%)
had attended the course, 31 women and 17 men. This is
16% of all the patients connected to the present diabetes
unit. Three persons came the first day but cancelled the
next visit. All the individuals were known to us. Most
had attended diabetes education before in the form of
diabetes schools, diabetes camps etc. Fourteen used in-
sulin pumps. There was no relation between the use of
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was 52 ±11.5 years and 24.0 ± 12 years respectively.
Seven individuals with gatro-paresis used domperidone
(motilium) in order to improve gastric motility.Weight, lipids and insulin
Table 1 shows mean weight and Body Mass Index
(kg/m2) (BMI) and lipids. In the group of adherent
people following changes were seen after 4 years: Mean
Tot-Chol. from 5.3 ± 0.9 to 5.6 ± 0.8 mmol/l (p = 0.04).
The increase was caused by an HDL increase from
1.5 ± 0.5 to 1.8 ± 0.4 mmol/l (p = 0.04). TAG was almost
unchanged. Ratio Chol/HDL was 3.6 and 3.2 (p = 0.035);
ratio TAG/HDL was 0.5 and 0.4 (P = 0.04) at start and
after 4 years respectively.
Meal insulin was reported for 36 patients. Mean daily
dosage changed as follows: at start 23 ±9 IU; 1 year
13 ± 6 IU. After 4 years the doses were only sporadically
reported. We have therefore not reported a mean. Mean
long-acting insulin: there was a modest change from
19.6 ± 5 IU to 18.6 ± 6 IU the first year.HbA1c
Forty eight persons with a HbA1c >6.1 attended the
course and could, based on HbA1c response and their
own information in the chart be divided in non-adherent
and adherent individuals. All achieved the expected
mean HbA1c reduction after 3 months. After 2 years
and onwards however, 25 persons (52%) had reverted
with respect to both mean HbA1c and diet. There are 4
designations in table and figure. Their meanings are: A =
all patients; B = non-adherent; C = partly adherent with
intra-person variations over time; D= adherent.Table 1 Mean weight and lipids in 48 patients with type
1 diabetes before and after 4 years of carbohydrate
reduction
Start 3 months P(1) 4 years P(2)
Weight(kg) 77.6± 15 74.9± 13.9 <0.001 76.7± 14.6 0.18
BMI (Kg/m2) 25.9± 3.5 25.0± 3.4 <0.001 25.7± 3.8 0.22
Tot-cholesterol
(mmol/l)
5.4± 1 5.6± 1.0 0.2 5.6± 0.9 0.44
HDL-cholesterol
(mmol/l)
1.5± 0.4 1.6± 0.5 0.03 1.7± 0.4 <0.001
Triacylglycerol(TAG)
(mmol/l)
0.9± 0.8 0.8± 0.5 0.04 0.9± 0.4 0.73
Ratio Chol/HDL 3.9± 1.2 3.5± 1.4 0.11 3.5± 1.0 <0.001
Ratio TAG/HDL 0.8± 1.2 0.6± 0.9 <0.001 0.6± 0.5 0.08
P(1) the p-value is for the difference between start and 3 months. P2) the p
value is for the difference between start and 4 years. TAG: triacylglycerols;
HDL: HDL-cholesterol; Chol: cholesterol.
The carbohydrates amount was reduced to 75 g/day or lower according to the
patient’s own preferences. The insulin doses reduced according to the
quantity of carbohydrates.The HbA1c changes in the groups are seen in Table 2
and Figure 2.
Cardiovascular disease
One person underwent percutanous coronary interven-
tion in the 4 years.
Discussion
After 2 years about half of the individuals had ceased ad-
hering. The other half (group C+D) achieved a stable
lowering of HbA1c. This is clinically significant. The tis-
sue destructions from hyperglycemia accumulate steeply
in the type 1 diabetes population [1]. The HbAc1 reduc-
tion therefore, even in this little group, already after a
few years corresponds to a number of people avoiding
complications [1].
The calculated number of persons who have avoided
complications over 4 years among the 23 persons are:
Retinopathy progression 2-3 persons (8-11%); laser treat-
ment 1 person (4%); neuropathy 5-6 persons (22-26%);
severe retinopathy 1 (4%). About 1 person (4%) per
5 years can be expected to avoid macular edema, and 1
person to avoid a cardiovascular event [1,2].
The ratio Chol/HDL is a marker of a specific risk for
myocardial infarction [11]. The changes here correspond
to a 20% reduction in this risk. The difference in HbA1c
reduces the risk of cardiovascular disease by about 40%
[1,2]. Substitution of fat for carbohydrates is generally
more beneficial for risk of cardiovascular disease in both
normal- and overweight persons than the widely recom-
mended low-fat diet [12].
There is no reason to assume that the patients here
are different from the rest of Sweden. The number of
adults with type 1 diabetes in Sweden is about 40,000
and the number cared for by the present diabetes unit is
about 300.
The 23 persons in group C+D constitute about 7.6%
of all persons with type 1 diabetes cared for by theTable 2 Mean HbA1c before and 4 years after
carbohydrate reduction in type 1 diabetes in groups with
different degrees of adherence
§Group n % start 3 mo. 4 years *Change % !p
All 48 100 7.6± 1.0 6.3± 0.7 6.9± 1.0 -0.7 ± 1.1 -8.4 ± 13 <0.001
B 25 52 7.5± 1.1 6.5± 0.8 7.4± 0.9 -0.1 ± 0.3 -0.7 ± 11 0.7
C +D 23 48 7.7± 1.0 6.4± 0.9 6.4± 0.8 -1.3 ± 0.9 -16 ± 10 <0.001
C 10 21 7.6± 1.0 6.3± 0.8 6.9± 0.8 -0.7 ± 0.4 -8.8 ± 4 <0.001
D 13 27 7.8± 1.0 6.5± 0.8 6.0± 0.6 -1.8 ± 0.9 -22.4 ± 8 <0.001
} A: all patients. B: non-adherent patients. C: partly adherent with intra-person
variations over time. D: with initial high HbA1c and excellent adherence. * The
HbA1c change between start and 4 years in HbA1c units. ! P-values are for
differences between start and 4 years.
Carbohydrates (mostly starch) were reduced to 75 g/day or lower. Insulin
doses adapted to the quantity of carbohydrates.
HbA1c
HbA1c
Figure 2 Mean HbA1c over 4 years after reduction of carbohydrates in all and in subgroups with different degrees of adherence. The
amount of carbohydrates was 75 g/day or less according to the person’s own preferences. Mainly, starchy food was reduced. The insulin doses
were adapted accordingly. }N number of patients in groups. A = all patients (100%). B = non adherent (52%). C = partly adherent with intra-person
variations over time. D = excellent adherence (27%). C +D (47%).
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about 3,100 adults with type 1 diabetes in Sweden who
might be expected to adapt to the present approach and
avoid a substantial number of complications.
A small group D, 27% of the subjects, without excep-
tion adapted excellently and achieved a constant mean
HbA1c lowering by 1.8 percentage point. This group
constitutes about 4.3% of all individuals with type 1 dia-
betes connected to the present unit, and corresponds to
about 1,700 of all adults with type 1 diabetes in Sweden.
Only a limited number of patients, about 16-18%, in
contact with the present unit have been interested in
such a change of diet as described.
There is no evidence for the use of the widely recom-
mended high-carbohydrate, low-fat diet in type 1
diabetes.
There is no evidence that animal fat in the food should
cause cardiovascular disease [13–15]. There is no evi-
dence that protein should cause kidney disease [16]; on
the contrary, hyperglycemia gave a 3.5 times higher inci-
dence of albuminuria in DCCT, not protein [1]. There
is, however, strong evidence for the aggressive develop-
ment of damages in all organs in poorly regulated type 1
diabetes [1].
The physician and the individual must therefore to-
gether explore the tools and methods that give best re-
sult, for instance type of insulin, insulin pens, insulin
pump etc. and diet. The restricted carbohydrate dietary
approach is directly aimed at lowering of HbA1c, not at
avoiding fat and protein. The model described here may
be an option for 10-20% of the patients with type 1
diabetes.Conclusion
An educational program involving a low-carbohydrate
diet and correspondingly reduced insulin doses for
informed individuals with type 1 diabetes gives accept-
able adherence after 4 years. One in two people attend-
ing the education achieves a long-term significant
HbA1c reduction.
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